Harrow Inc
Nasdaq HROW · Nashville, TN
Works in Cardiovascular · Metabolic & endocrine · Ophthalmology
Harrow Inc is a clinical trial sponsor based in Nashville, TN, listed as Nasdaq HROW. It has 2 active clinical trials with 486 planned participants, in Cardiovascular, Metabolic & endocrine and Ophthalmology. Since 2021 it has completed 2 trials and stopped 0 early.
Trial track record · since 2021
Financials · Nasdaq HROW
Pipeline · 2 active trials
| Stage | Trial | Status |
|---|---|---|
Questions about Harrow Inc
Harrow Inc is lead sponsor of 2 active clinical trials on ClinicalTrials.gov, with 486 planned participants, in Cardiovascular, Metabolic & endocrine, Ophthalmology. Since 2021 it has completed 2 trials and stopped 0 early.
Harrow Inc is based in Nashville, TN and is listed as Nasdaq HROW. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Harrow Inc; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-09-22.
Approve Suite is not affiliated with Harrow Inc. Informational only.
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.